Moderna
MRNA
#296
Rank
C$111.98 B
Marketcap
C$276.76
Share price
-3.13%
Change (1 day)
715.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$6.01 Billion

According to Moderna 's latest financial reports the company's total liabilities are C$6.01 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$5.05 B8.6%
2024-12-31C$4.65 B-23.31%
2023-12-31C$6.06 B-33.65%
2022-12-31C$9.13 B-31.86%
2021-12-31C$13.41 B120.24%
2020-12-31C$6.08 B1024.59%
2019-12-31C$0.54 B-7.96%
2018-12-31C$0.58 B1.91%
2017-12-31C$0.57 B-25.33%
2016-12-31C$0.77 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$166.10 B 2,659.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$114.06 B 1,794.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$125.86 B 1,990.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$8.31 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$62.8 M-98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$6.29 B 4.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$2.35 B-60.81%๐Ÿ‡บ๐Ÿ‡ธ USA